about
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Con...
Read More
19.87
0.75
(3.92%)
161.7K
XNAS Volume
XNAS 27 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Neurogene Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..